| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.5M | -8.5% |
| Cost of Revenue | $5.1M | -3.7% |
| Gross Profit | $3.4M | -14.7% |
| R&D Expense | $2.2M | +22.2% |
| SG&A Expense | $1.3M | +7.1% |
| Operating Income | -$1.4M | -636.8% |
| Interest Expense | $40K | -3.4% |
| Income Tax | -$353K | +4.3% |
| Net Income | -$1.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $733K | -9.8% |
| Inventory | $3.0M | -0.9% |
| Current Assets | $5.1M | -10.8% |
| Total Assets | $8.7M | +0.4% |
| Current Liabilities | $744K | -35.3% |
| Long-term Debt | $1.1M | -4.4% |
| Total Liabilities | $2.5M | +7.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -152.5% |
| Capital Expenditures | $540K | +7824.4% |
| Investing Cash Flow | -$689K | -8292.5% |
| Financing Cash Flow | $1.5M | +2963.8% |
| Free Cash Flow | -$1.9M | -250.7% |
| -612.1% |
| EPS (Basic) | -$0.41 | -612.5% |
| EPS (Diluted) | -$0.41 | -612.5% |
| Stockholders' Equity |
| $6.2M |
| -2.1% |